Blood Pressure Monitoring for Minoxidil Therapy in Alopecia Patients

Main Article Content

Colin Kincaid
Justin Arnold
Celine Phone
Minjun Park
Arash Babadjouni
Natasha Mesinkovska


alopecia, blood pressure, low-dose oral minoxidil, androgenetic alopecia, alopecia areata


1. Jimenez-Cauhe J, Saceda-Corralo D, Hermosa-Gelbard A, et al. Before-after study with 24-hour ambulatory blood pressure monitoring after the first dose of 5 mg oral minoxidil. J Am Acad Dermatol. 2022;87(6):e235-e237. doi:10.1016/j.jaad.2022.06.1205

2. Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, et al. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-1651. doi:10.1016/j.jaad.2021.02.054

3. Panchaprateep R, Lueangarun S. Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment. Dermatol Ther (Heidelb). 2020;10(6):1345-1357. doi:10.1007/s13555-020-00448-x

4. Perera E, Sinclair R. Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study. F1000Res. 2017;6:1650. doi:10.12688/f1000research.11775.1